Furthermore, the sensitivity and accuracy of MS-HRM is comparable to that of bisulfite sequencing suggesting that MS-HRM could be used as a rapid, sensitive and economical method for assessing HOXA2 methylation in both tumors and plasma samples of NPC patients. The gene discussed is HOXA2; the disease is nasopharyngeal carcinoma.